Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?

Michael A Borger1, Mark Preston, Joan Ivanov

  • 1Division of Cardiovascular Surgery, Toronto General Hospital, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4. michael.borger@uhn.on.ca

Insights

For bicuspid aortic valve disease, ascending aorta replacement is recommended at 4.5 cm or greater. This helps prevent serious aortic complications and improve long-term outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Genetics

Background:

  • Bicuspid aortic valve disease is a common congenital heart defect.
  • The optimal management strategy for ascending aorta dilation in these patients remains unclear.

Purpose of the Study:

  • To determine the optimal diameter for ascending aorta replacement in patients with bicuspid aortic valve disease.
  • To assess the risk of aortic complications based on ascending aorta diameter.

Main Methods:

  • Retrospective review of 201 patients with bicuspid aortic valves undergoing aortic valve replacement between 1979 and 1993.
  • Exclusion of patients who had concomitant ascending aorta replacement.
  • Long-term follow-up to assess survival and aortic complications.

Main Results:

  • Fifteen-year freedom from ascending aorta complications was significantly lower in patients with diameters 4.5-4.9 cm (43%) compared to <4.0 cm (86%) and 4.0-4.4 cm (81%).
  • Ascending aorta-related complications included aneurysm, dissection, and sudden cardiac death.
  • A diameter of 4.5 cm or greater was associated with a substantially increased risk of complications.

Conclusions:

  • Concomitant ascending aorta replacement should be strongly considered for patients with bicuspid aortic valve disease when the diameter reaches 4.5 cm or greater.
  • Early intervention can mitigate the risk of severe aortic events in this population.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...